Want to see JP:3750 full AI Analyst Report?
Cytori Cell Research Institute, Inc. (3750) Financial Statements
Cytori Cell Research Institute, Inc. Financial Overview
Cytori Cell Research Institute, Inc.'s market cap is currently $7.14B. The company's EPS TTM is $-62.76; its P/E ratio is -12.75; and it has a dividend yield of 1.06%. Cytori Cell Research Institute, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 50.99M | $ 122.20M | $ 1.56B | $ 2.14B | $ 1.34B |
| Gross Profit | $ 9.87M | $ -55.56M | $ 1.08B | $ 988.61M | $ 622.73M |
| Operating Income | $ -906.17M | $ -806.89M | $ -772.74M | $ -794.36M | $ -462.32M |
| EBITDA | $ -905.48M | $ -757.31M | $ -518.43M | $ -462.87M | $ -141.28M |
| Net Income | $ -396.90M | $ -2.14B | $ 138.16M | $ -1.06B | $ -77.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 125.90M | $ 255.98M | $ 1.04B | $ 1.12B | $ 851.56M |
| Total Assets | $ 368.06M | $ 3.54B | $ 5.82B | $ 14.09B | $ 16.01B |
| Total Debt | $ 0.00 | $ 2.65B | $ 2.47B | $ 8.51B | $ 9.27B |
| Net Debt | $ -125.90M | $ 2.39B | $ 1.43B | $ 7.38B | $ 8.42B |
| Total Liabilities | $ 346.03M | $ 2.91B | $ 3.02B | $ 11.43B | $ 12.29B |
| Stockholders' Equity | $ 22.02M | $ 630.54M | $ 2.79B | $ 2.65B | $ 3.71B |
| Cash Flow | |||||
| Free Cash Flow | $ -784.77M | $ -995.12M | $ -1.17B | $ -198.04M | $ -367.83M |
| Operating Cash Flow | $ -784.77M | $ -987.04M | $ -1.15B | $ -39.52M | $ -187.78M |
| Investing Cash Flow | $ 2.98B | $ 22.90M | $ 8.69B | $ -283.06M | $ -216.19M |
| Financing Cash Flow | $ -2.32B | $ 171.65M | $ -7.17B | $ 294.23M | $ 35.80M |
Currency in JPY
